JCI
WAT
CC

Mark Vergnano

Known title: DirectorCIK: 0001474107

Mark Vergnano's purchase track record

Mark Vergnano has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.

PurchaseStockAmount3 months6 months
2/5/2026JCI$1.01M+5.4%+17.3%
2/28/2023WAT$998K-17.8%-7.4%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

JCI Sees AI Data Center Cooling Growth, Analysts Maintain Coverage. Johnson Controls is positioning itself to capture growth in the expanding data center cooling market, driven by AI and GPU heat loads. Analysts have maintained their coverage of the company, noting its role in U.S. manufacturing and AI infrastructure buildouts. The company's cooling solutions are in high demand as hyperscale data center capacity continues to expand.

this person other insiders at JCI

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Waters Launches AI Link for LC-MS Workflows. Waters Corporation introduced AI Link, a tool designed to advance AI-enabled LC-MS workflows from research to release. This product launch highlights the company's focus on integrating artificial intelligence into its laboratory solutions. Additionally, TD Cowen raised its price target to $515, reflecting continued analyst interest in the stock's potential.

this person other insiders at WAT

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 12, 2026

Chemours Q2 Earnings Call and UBS Price Target Cut. Chemours released its Q2 2026 earnings call transcript, providing details on its financial performance. UBS kept a neutral stance but lowered its price target to $16, reflecting a more cautious view of the company's outlook. The new target sits below the current average analyst target of $18.22 and near the support level of $15.07, indicating a potential short‑term pressure on the stock.

this person other insiders at CC

Transaction History

JCI▲ Buy$0
JCI▼ Sell$156K
WAT▲ Buy$0
JCI▼ Sell$0
JCI▼ Sell$0
JCI▲ Buy$1.0M
JCI▼ Sell$0
JCI▼ Sell$0
WAT▲ Buy$0
JCI▼ Sell$111K
JCI▲ Buy$0
WAT▲ Buy$0
JCI▲ Buy$0
JCI▼ Sell$86K
WAT▲ Buy$0
JCI▲ Buy$0
JCI▲ Buy$87K
WAT▲ Buy$998K
WAT▲ Buy$0
WAT▲ Buy$0
JCI▼ Sell$88K
JCI▲ Buy$0
CC▼ Sell$244K
CC▲ Buy$0
CC▼ Sell$501K
CC▼ Sell$3.0M
CC▲ Buy$1.8M
CC▲ Buy$199K
CC▼ Sell$378K
CC▼ Sell$3.1M
CC▲ Buy$1.6M

We use analytics to understand how market-wall is used. No personal data is sold.